1. 广州中医药大学第一附属医院
2. 广州中医药大学第三附属医院
纸质出版:2019
移动端阅览
[1]陈宝艳,李坤寅,甄玉花.疏肝健脾方对产后缺乳肝郁脾虚证模型大鼠JAK2/STAT5A信号通路的影响[J].中医杂志,2019,60(10):876-880.
CHEN Baoyan, LI Kunyin, ZHEN Yuhua. Effects of Shugan Jianpi Recipe(疏肝健脾方) on JAK2/STAT5A Signaling Pathway in Model Rats of Postpartum Hypogalactia With Liver Depression and Spleen Deficiency Syndrome[J]. Journal of Traditional Chinese Medicine2019, 60(10): 876-880.
[1]陈宝艳,李坤寅,甄玉花.疏肝健脾方对产后缺乳肝郁脾虚证模型大鼠JAK2/STAT5A信号通路的影响[J].中医杂志,2019,60(10):876-880. DOI: 10.13288/j.11-2166/r.2019.10.015.
CHEN Baoyan, LI Kunyin, ZHEN Yuhua. Effects of Shugan Jianpi Recipe(疏肝健脾方) on JAK2/STAT5A Signaling Pathway in Model Rats of Postpartum Hypogalactia With Liver Depression and Spleen Deficiency Syndrome[J]. Journal of Traditional Chinese Medicine2019, 60(10): 876-880. DOI: 10.13288/j.11-2166/r.2019.10.015.
目的探讨疏肝健脾方治疗产后缺乳肝郁脾虚证的可能作用机制。方法 60只Wistar临产期孕鼠随机分为模型组、空白对照组、西药对照组和疏肝健脾方低、中、高剂量组
每组10只。除空白对照组外
其余各组大鼠产后采用甲磺酸溴隐亭溶液+慢性束缚法复制大鼠产后缺乳肝郁脾虚病证模型。造模后西药对照组予甲氧氯普胺片溶液3. 15 mg/(kg·d)灌胃
疏肝健脾方低、中、高剂量组分别给予浓度为1. 109、2. 218、4. 435 g/ml疏肝健脾方溶液每只5 ml灌胃
模型组、空白对照组予等体积蒸馏水灌胃
各组均每日早、晚各灌胃1次
连续7天。采用RT-PCR法检测乳腺组织中酪氨酸激酶2 (JAK2)、信号传导及转录激活因子5A (STAT5A)、催乳素受体(PRLR)和β-酪蛋白(β-casein) mRNA表达
采用Western blot法检测乳腺组织中JAK2、STAT5A、PRLR和β-casein蛋白表达。结果与空白对照组比较
模型组、西药组和疏肝健脾方低、高剂量组大鼠乳腺组织JAK2、STAT5A、PRLR及β-casein mRNA及蛋白水平显著降低(P <0. 05)
而疏肝健脾方中剂量组差异无统计学意义(P> 0. 05)。与模型组比较
西药对照组和疏肝健脾方各剂量组大鼠乳腺组织JAK2、STAT5A、PRLR及β-casein mRNA及蛋白水平均升高
且疏肝健脾方中剂量组明显高于其余给药组(P <0. 05)。结论疏肝健脾方治疗产后缺乳肝郁脾虚证的机制可能与其促进催乳素与其受体结合
激活JAK2/STAT5A信号转导通路
并上调β-casein基因表达相关。
Objective To explore the possible mechanism of Shugan Jianpi Recipe( 疏肝健脾方) in the treatment of postpartum hypogalactia of liver depression and spleen deficiency syndrome. Methods A total of 60 Wistar pregnant rats with due date were randomly divided into model group
blank control group
western medicine control group and Shugan Jianpi Recipe low
medium and high dose groups
with 10 rats in each group. Except the blank control group
the rats were established the model of postpartum hypogalactia of liver depression and spleen deficiency syndrome using bromocriptine mesylate + chronic restraint method. After modeling
the western medicine control group was given 3. 15 mg/( kg·d) of metoclopramide tablet solution
and the Shugan Jianpi Recipe low
medium and high dose groups were intragastrically administered with 1. 109
2. 218
4. 435 g/ml of Shugan Jianpi Recipe solution respectively
5 ml per rat. The model group and the blank control group were intragastrically administered with equal volume of distilled water. Each group was intragastrically administered once in the morning and evening for 7 days.Reverse transcription-polymerase chain reaction( RT-PCR) was used to detect the expression of tyrosine kinase 2( JAK2)
signaling and transcriptional activator 5 A( STAT5A)
prolactin receptor( PRLR) and β-casein mRNA in breast tissue. The expression of JAK2
STAT5A
PRLR and β-casein protein in breast tissue was detected by Western blot. Results Compared with the blank control group
the levels of JAK2
STAT5A
PRLR and β-casein mRNA and protein in the mammary gland in the model group
the western medicine group and the Shugan Jianpi Recipe low and high dose group were significantly decreased( P < 0. 05)
while there was no significant difference in the Shugan Jianpi Recipe middle dose group( P > 0. 05). Compared with the model group
the levels of JAK2
STAT5A
PRLR and β-casein mRNA and protein in the mammary gland of rats in the western medicine control group and all Shugan Jianpi Recipe groups were increased
and the middle dose group was significantly higher than the other drug groups( P <0. 05). Conclusion The mechanism of Shugan Jianpi Recipe in the treatment of postpartum hypogalactia of liver depression and spleen deficiency syndrome may be related to the promotion of prolactin binding to its receptor
activation of JAK2/STAT5A signal transduction pathway
and up-regulation of β-casein gene expression.
0
浏览量
372
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号